Featured Stories
Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

New Jersey Appeals Court Considering Facebook Ethics Case

A New Jersey appeals court is considering whether the Office of Attorney Ethics has the power to file ethics grievances against lawyers after district ethics committees have declined to do so, and whether the judges themselves even have the authority to get involved in the dispute.

If the panel decides that the Superior Courts can exercise jurisdiction over ethics matters, it will then have to decide whether OAE Director Charles Centinaro violated the rules governing the disciplinary process when he filed a complaint against two lawyers in Hackensack, after District II-B Ethics Committee secretary Doris Newman concluded their actions did not constitute unethical conduct, New Jersey Law Journal reports. Continue reading

Posted in Legal News |

Limited Data Available on Medication Dosage for Kids

When it comes to prescribing medication for children, there is often little data to support information about dosage, safety or efficiency. According to Scientific American, most clinical trials do not include children so the burden of deciding what treatments to use and how falls on physicians.

Scientific American reports that only 46 percent of drugs used in kids have been approved by the U.S. Food and Drug Administration (FDA) for pediatric use. In the past, that statistic was far worse. Continue reading

Posted in Legal News |

Trinity Industries Accused of Hiding Failed Crash Tests in Whistleblower Trial over Guardrails

In a trial over its guardrails, Trinity Industries was questioned about why they did not tell authorities about five failed crash tests. The New York Times reports that the case was filed under the False Claims Act by a competitor who alleged that the company violated federal rules when it failed to notify the Federal Highway Administration that it modified the design of its ET-Plus rail head in 2005.

These guardrails are the subject of the safety concerns outside of this federal lawsuits, according to The New York Times. Last month, the states of Missouri and Massachusetts banned the design and began their own investigations. Virginia also took issued with Trinity, and said in a letter that it believes the company failed to adequately test the ET-Plus. The state wants further testing. Continue reading

Posted in Legal News |

Jury Problems Not Enough to Reverse No-Cause Verdict

Despite indications that a jury might have misunderstood what evidence it was allowed to consider and that one juror called the plaintiff a liar in a discussion outside the jury room, an appeals court found there were not sufficient grounds to reverse the no-cause verdict.

The appeals court upheld the verdict and the trial judge’s denial of a request for either post-verdict questioning of the jurors or a new trial. The plaintiff had sued over whiplash injuries to her neck allegedly from a 2010 automobile accident, where her car was rear ended and her head slammed into the back of her seat, the New Jersey Law Journal reports. Continue reading

Posted in Accident, Legal News |

Class Action Lawsuit over Infuse Could Complicate Medtronic Acquisition of Covidien

A class action lawsuit over Medtronic’s bone growth product Infuse could complicate the company’s planned acquisition of Dublin-based device maker Covidien.

U.S. District Judge John Tunheim will allow lawyers for Medtronic investors to explore an alleged coverup of Infuse’s side effects by Medtronic officials, the Minneapolis Star Tribune reports. Off-label use of Infuse has allegedly injured thousands of patients. Tunheim said the plaintiffs could pursue their claim that former Medtronic CEO William Hawkins purposely made misstatements to stock analysts to hide the fact that the Food and Drug Administration (FDA) had refused to approve Amplify, the next iteration of Infuse. Continue reading

Posted in Class Action Lawsuits, Defective Medical Devices, Legal News, Medtronic Infuse |

Sugary Sodas may be Linked to Higher Risk of Rheumatoid Arthritis

According to a study recently published in The American Journal of Clinical Nutrition, women are more likely to develop rheumatoid arthritis (RA) if they drink one or more sugar-sweetened sodas a day compared those who drink less than one soda per month or less.

According to the Arthritis Today, RA leads to inflammation and subsequent joint pain and damage, fatigue and other consequences. It is a systemic, autoimmune disease believed to be caused by a combination of genetic and environmental factors. Continue reading

Posted in Legal News |

European Scientific Committee Urges Caution on Metal-on-Metal Hips

SCENHIR, the European Union’s Scientific Committee on Emerging and Newly Identified Health Risks, has issued an opinion on the safety of metal-on-metal (MoM) joint replacement devices, with “particular focus” on hip implants.

The committee examined concerns over possible exposure to cobalt and/or chromium after MoM-hip resurfacing or replacement that can lead to organ toxicity, carcinogenicity and teratogenicity (malformation of the fetus). Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants |

Safety Alert Issued for Covidien Defibrillator Electrodes

A Field Safety Alert was issued for some of Covidien’s defibrillator electrodes. According to the alert, certain Medi-Trace Cadence and Kendall Multi-function Defibrillation Electrodes will not connect with Philips FR3 and FRx Defibrillators. There are at least two reported incidents “where customers attempted to use a Covidien electrode with a Philips FR3 AED unit. The mismatch of these devices contributed to a delay in resuscitation and may have contributed to the subsequent death of one patient.”

An automated external defibrillator (AED) is a portable device that attempts to correct a life-threatening heart rhythm using electrical shocks. The alert states that the Philips FR3 and FRx AED units are not compatible with certain Medi-Trace Cadence and Kendall Multi-function Defibrillation Electrodes; trying to pair these AEDs with the electrodes will delay therapy that can save a patient’s life. The FRx AED requires the pads to be connected before use, so a continuous chirp alarm will notify the user that the appropriate pads are not connected before the device is used. The FR3, on the other hand, does not require the pads to be connected beforehand; therefore, the users will not realize that the electrodes are incompatible until the unit needs to be used, causing a delay in therapy. Continue reading

Posted in Legal News |

Urgent: October 14 Deadline for 9/11 Responders to Register for Cancer Compensation

September 11th responders and survivors who were diagnosed with certain cancers prior to October 12, 2012, must register with the September 11th Victim Compensation Fund (VCF) or they become ineligible to file claims for the program’s benefits.

At an October 7 press conference, Rep. Peter King said, “We must ensure that our 9/11 heroes receive the care they deserve and are not left fighting alone because of ineligibility.” He urged anyone who might be eligible for compensation “to visit VCF.gov immediately and determine if you should register to preserve your right to file a claim.” Representatives Carolyn B. Maloney and Jerrold Nadler, along with Rep. King and a group of 9/ll responders, labor leaders, community representatives and advocates for 9/11 survivors, held the press conference to alert the public to the deadline, 9/11 Health Watch reports. Continue reading

Posted in Health Concerns, Toxic Substances, Zadroga Act Claims |

Senators Call on FDA to Mandate Strong Warning Labels for E-cigarettes

In a letter to FDA Commissioner Margaret Hamburg, a group of Democratic senators is urging the Food and Drug Administration (FDA) to require strong warning labels for e-cigarettes.

Senators Barbara Boxer, Dick Durbin, Richard Blumenthal, Jack Reed, Sherrod Brown, and Ed Markey wrote to Dr. Hamburg last week to ask her to finalize proposed rules expanding the agency’s ability to regulate all nicotine products, The Hill reports. Continue reading

Posted in Health Concerns, Toxic Substances |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.